Garret Gaughan’s Post

We're excited to announce the launch of our latest report on the life science sector, based on insights from our second Life Science Global Survey! This comprehensive overview explores the rapid evolution and challenges in the industry, including advancements in gene and cell therapies, biologics and vaccines. Key concerns from our survey of 400 senior decision-makers include regulation, data privacy, talent shortages and rising development costs. Despite these hurdles, companies are exploring new markets, launching new products, and leveraging automation for efficiency. Our report offers invaluable insights to help you navigate the complex life sciences landscape with confidence. Download a copy of your free report here: https://ow.ly/vNEI50SqN2z #LifeSciences #Innovation #Biotech #Pharma #RiskManagement #WTWDirectandFac

We're excited to announce the launch of our latest report on the life science sector, based on insights from our second Life Science Global Survey! This comprehensive overview explores the rapid evolution and challenges in the industry, including advancements in gene and cell therapies, biologics and vaccines. Key concerns from our survey of 400 senior decision-makers include regulation, data privacy, talent shortages and rising development costs. Despite these hurdles, companies are exploring new markets, launching new products, and leveraging automation for efficiency. Our report offers invaluable insights to help you navigate the complex life sciences landscape with confidence. Download a copy of your free report here: https://ow.ly/zfc750Sr3JT #LifeSciences #Innovation #Biotech #Pharma #RiskManagement #WTWDirectandFac

In the Global life sciences risk report 2024, 400 senior decision-makers impart their views on the sector’s emerging risks and challenges. Explore the rapid growth in gene and cell therapies, biologics and vaccines - despite high costs, talent shortages, regulation concerns and raw material scarcity.

📢 Unleashing the Power of Collaboration in Life Sciences with TraceLink! 🌟 Hear from Ulpiano Flores, a Serialization Consultant at Converge, who shares his expertise on leveraging the TraceLink network to drive success in biotech, pharmaceuticals, and cell and gene therapy industries. Here’s why TraceLink stands out: 🚀 Comprehensive Supply Chain Collaboration: TraceLink's unique advantage lies in its extensive collaboration across the supply chain—from manufacturers to CMOs, 3PLs, and pharmacies. This holistic approach ensures solutions that are tailored to every stakeholder's needs. 🌐 Scaling with Growth: A client story that truly inspires! Starting with TraceLink for EPCIS data transmission, our client expanded their serialization capabilities as they grew. Today, they manage multiple 3PL locations, CDMOs, and global market modules, all integrated seamlessly with TraceLink. 🤝 Thriving Partnership: At Converge, our partnership with TraceLink is more than just business; it's a collaborative effort to meet DSCSA objectives. Discover how TraceLink and Converge work hand-in-hand to ensure systems are up and running, meeting compliance goals, and supporting growth. Watch the full video to learn more! 🎥👇 #LifeSciences #Pharmaceuticals #SupplyChain #Serialization #TraceLink #Converge #DSCSA #Biotech #Innovation #Growth #Tracelink

🧬 𝐇𝐨𝐰 𝐭𝐨 𝐦𝐚𝐤𝐞 𝐂𝐀𝐑 𝐓 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐦𝐨𝐫𝐞 𝐞𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞 CAR-T therapies are rapidly expanding beyond blood cancers. However, manufacturing costs and achieving high yields remain significant challenges. Lentiviral vectors are a critical part of the process, as they deliver genetic material to T cells. Small changes, such as modifying the buffers, can improve stability and efficiency, making the manufacturing process more cost-effective and scalable. #cart # #pharma #biotech #drjojo ---------- Hi! I am Joanna, and my friends call me Dr Jojo 🌸 𝐈 𝐭𝐚𝐥𝐤 𝐚𝐛𝐨𝐮𝐭 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐛𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐢𝐧 𝐩𝐡𝐚𝐫𝐦𝐚 𝐚𝐧𝐝 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 ♻️ Share this if you find it interesting 🔔 Follow for insights you won't want to miss

6 days to go - and then you can discover the 6 innovation topics at #ACHEMA2024! #processinnovation #greeninnovation #pharmainnovation #hydrogeninnovation #labinnovation #digitalinnovation - those are not just buzzwords, they reflect trends that transform the chemical, biotech, pharma and other process industries. Use the hashtags to find your topic of interest in the program or just come to the innovation stages and experience learn about the latest developments first-hand from experts. And if you want to implement innovative technologies in your plant, you find everything you are looking for in the exhibition. https://lnkd.in/eC8WyZru

Global #Genome #Editing Market: By Application (Cell Line Engineering, Genetic Engineering, Drug Discovery, Gene-modified Cell Therapy, Diagnostics, and Other Applications), By Technology (CRISPR, TALEN, ZFN, and Other Technologies), By End User (Academics & Government Institutes, Biotechnology & Pharma Companies, and Contract Research Organizations), and Region : Cumulative Growth Opportunities Analysis, Size, Share, Trends, and Industry Forecast Till 2030. By: Analytical Market Research Read More Info:https://lnkd.in/dVdCccsT Key Players: CRISPR Therapeutics , GenScript , Thermo Fisher Scientific, Merck KGaA, Darmstadt, Germany, PerkinElmer., Eurofins Scientific Finland Oy, Danaher Corporation, Editas Medicine, AL Group Lonza . #marketgrowth #marketshare #marketsize #marketdemands #marketforecast #marketstretargy #marketanalysis #markettrends #market

Munzai Solutions helped Genscript Book 20 High Profile Meetings. GenScript has been a pioneer in the biotech industry.  Their commitment to personalized medicine. Along with providing essential reagents for gene editing. And therapeutic advancements have been nothing less than inspiring. Our partnership has leveraged GenScript’s expertise. And their innovative GMP facility. To produce biotech components like  - sgRNA  - minicircle/ss/dsDNA  More efficiently and cost-effectively.  This has not only supported laboratories worldwide. But it also accelerated the availability of life-changing therapies. Through targeted outreach in Europe, Munzai Solutions has helped Genscript connect with biotech professionals. Ensuring quick access to these critical reagents.  While exceeding compliance standards. This strategic collaboration has set a new benchmark for operational excellence. And has fostered long-term partnerships. That redefines biotechnology. And enhance patient outcomes. P.S. Want to Read the Full Case Study? Click the Link in the first comment! P.S.S. Book a 30 Minutes Sales Consultation with Munzai Solutions 👇 #MunzaiSolutions #Genscript #ClientSuccessStory  

✴ The pharmaceutical industry is evolving rapidly, driven by cutting-edge technologies and innovative therapies. Here are five key trends shaping its future: 🔹 Personalized Medicine: Tailor-made treatments based on genetic data improve outcomes and reduce side effects. 🔹 AI & Big Data: Revolutionizing drug discovery, AI reduces costs and enhances precision in therapy identification. 🔹 Digital Health: Wearables enable real-time tracking of treatment efficacy and patient well-being. 🔹 Biologics & Gene Therapies: Advanced therapies offer hope for previously untreatable conditions. 🔹 Sustainability: Pharma focuses on eco-friendly innovations, addressing global health challenges sustainably. Let's work together to make healthcare more personalized, accessible, and sustainable for a healthier future. #FutureOfPharma #PharmaInnovation #AIinHealthcare #PersonalizedMedicine #Biotech #DigitalHealth

𝐂𝐞𝐥𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞 𝐭𝐨 𝐇𝐢𝐭 $𝟕.𝟖 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟖 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://lnkd.in/dWt7jVxt The global size of cell therapy technologies market in terms of revenue was estimated to be worth $4.2 billion in 2023 and is poised to reach $7.8 billion by 2028, growing at a CAGR of 13.3% from 2023 to 2028 Companies Operating in this Market Globally Thermo Fisher Scientific Merck KGaA, Darmstadt, Germany Danaher Corporation Lonza Sartorius Terumo Blood and Cell Technologies BD Fresenius Kabi Avantor Bio-Techne Corning Incorporated FUJIFILM Irvine Scientific MaxCyte, Inc. Werum IT Solutions GmbH RoosterBio Inc. SIRION BIOTECH GmbH (Revvity Gene Delivery) TrakCel L7 Informatics Miltenyi Biotec STEMCELL Technologies GPI IBERIA MAK-SYSTEM OrganaBio iXCells Biotechnologies Wilson Wolf Manufacturing, LLC